Chief Information Officer (CIO) & Digital Transformation Leader (CDO), Strides
Chief Information Officer (CIO) & Digital Transformation Leader (CDO), Strides
Anjani is hands-on digital leader and true business partner who specializes in transforming teams, processes and digital products. His variety of experiences in Strategy & IT Operations (Nissan and Safexpress), IT & Digital Products (IBM & Collabera) as well as Digital Platforms (IBM and Cognizant) provides him edge in working with stakeholders from Business as well as Technology. Most prestigious technology forums have recognized him for his outstanding contribution in Digital Transformation using cutting edge (AI, Mobility, Cloud and IoT) technologies. Apart from managing Digital & IT, he has also managed captive digital center for Capability Building, Re-skilling, Hiring, Retention and Overall Operation.
Before moving to corporate C-level roles, Anjani had 14 years accelerated tenure (including 7 years in USA) at IBM, including establishing Digital Business Unit for Pharmaceutical & Life Sciences outsourcing industry with P&L responsibilities. Exposed to numerous industries including Pharmaceutical, Services, Telecom, Automobile, Retail and Media, he has worked for fortune 500 organizations such as AT&T, Pfizer, IBM, Nissan, Cognizant and Ranbaxy. He is also speaker on digital innovation including AI, RPA, cloud & IoT and regular to round table & media publications (ET, Mint, Indian Express, DataQuest & other digital media forums).
Senior Vice President @ Zydus Cadila
Senior Vice President @ Zydus Cadila
Committed Business Leader with 24+years of insightful experience in General Management, Sales, Marketing & functional leadership with expertise in Pharmaceuticals. I am passionate in delivering results by building winning teams.
In current role @Zydus Cadila, I had the opportunity to lead Acute as well as Chronic therapy businesses – Antibiotics, GI, Cardiology/ Metabolics, Orthopedics, Rheumatology in last over 11 years. Currently leading Commercial Excellence/ Strategy SFE, Portfolio, Key accounts, & Marketing excellence cluster.
Prior to this, I worked with Ranbaxy & Torrent Pharma….with proven results in devising winning sales & marketing strategies aimed to enhance market share. I have contributed in building some large brands amongst top 300 of Industry – Nexpro/ Nexpro RD, Domstal, Droxyl, Sporidex, Rosuvas, Ocid, Aten, Oxalgin, Pantodac, Nucoxia, Amlodac, Amicin, Thrombophob, Ampilox, Monotax, Falcigo etc.
I have exposure in integrating role – establishing synergies and operational excellence in cross functional working aligned to revenue objectives.
The leadership style followed is built on trust, respect & fairness, to create environment in which each team members feel that they are part of exciting journey which will add value to them – personally challenging & empowering them to make significant contributions that positively impacts our customer & overall success of our company. This provides me ability to manage both scale & complexity, driving transformational change in start-up & scale up business situations.
Former executive Director, Takeda Pharmaceutical
Former executive Director, Takeda Pharmaceutical
Over 39years of experience in Global Pharmaceutical MNCs as a Successful Manager in various roles - General Management , Marketing & Sales roles & Excelling in diverse multicultural environments . A strong proponent for Building Big Brands & enhancing Corporate Equity through Patient & Customer Focus, Ensuring Total Compliance & Corporate Governance . Launched & Built Brands in Multiple Therapeutic segments ,& managed overall P&L of Business . Actively involved in Mergers, Acquisitions & Integrations , Change Management process without losing sight on Performance& Compliance . Developed Human Capital through Continuous Training &Development programs which led to Attracting & Retaining Top Talents .Encourage Innovation & promote / Create Healthy Competitive working environment . Have always created a working environment of Trust , Fairness ,Openness , Integrity , Compliance & Corporate Governance .
Was associated with Anderson Consulting for Business Process Re Engineeringproject . Have attended various Marketing & General Management programmes in reputed institutes like INSEAD ( Singapore ) , IIM Ahmedabad , Bangalore & ASCI Hyderabad.
Vice President & Head Human Resources - Research & Development | Glenmark Pharmaceuticals Ltd
Vice President & Head Human Resources - Research & Development | Glenmark Pharmaceuticals Ltd
As the HR Leader for Research & Development and science led enabling functions at Glenmark, I’m focused on empowering our 1200+ global employees to achieve the organization's mission. I partner with them in creating a culture that attracts and inspires some of the most passionate scientific talent in the generic, specialty & innovative medicines domain. Previously, in addition to leading HR for R&D and enabling functions , I was also entrusted with the responsibility of leading two COE teams in Glenmark globally - Talent Acquisition and People Success (Engagement & Recognition). I led our Employer Brand Strategy with a goal to significantly enhance Glenmark’s status as an Employer of Choice. With Glenmark People Success (Employee Engagement & Recognition), we created and sustained an environment where our people could do their best work. We continuously researched, drew insights and solved for - what makes Glenmarkians tick!
I take pride in serving a team that gets up every day thinking about how they can create extraordinary value through their relentless pursuit in ensuring high quality medicines become more accessible and affordable across the world.
Prior to Glenmark, I spent five years pursuing my entrepreneurial dreams, during this time I set up two ventures. First, a talent assessment and measurement venture for India and SAARC region - was acquired by Hay group in 2015. Second, an ahead-of-its-time online venture focused on providing career intelligence to students and professionals.
Being in the thick of two large scale global HR transformations, five complex digital transformations, early responsibility as the global head of rewards and HR operations for one of India's largest conglomerates, partnering Promoter groups/CEOs on several leadership acquisitions sums up the rest of my career.
Throughout my professional career, I have aligned HR and talent strategies to improve business performance and drive outcomes. As a leader, I believe in creating high impact by fostering trust in the team and fueling excellence. My idea of finding business solutions are - customer-inspired, data-led and holistically thought through. I am pragmatic and believe in simplicity being the ultimate sophistication.
Value Evidence Expert, Sanofi
Value Evidence Expert, Sanofi
Vice President & Head, Clinical R&D, Cipla
Vice President & Head, Clinical R&D, Cipla
Internationally experienced industry physician (MD) and R&D leader with 20 years of experience in leading clinical development, clinical pharmacology, translational research, biopharmaceutics and preclinical functions in multinational pharma and academic
Director Genomics & Biotechnology at WOCKHARD
Associate Vice-President and Head of R&D – differentiated formulations Dr. Reddy’s Laboratories Ltd,
Associate Vice-President and Head of R&D – differentiated formulations Dr. Reddy’s Laboratories Ltd,
Dr. Pirthi Pal Singh is an Associate Vice-President and Head of R&D – differentiated formulations at Dr. Reddy’s Laboratories Ltd, India.
He earned his M. Tech. and PhD. Tech. in Bioprocess Technology from ICT Mumbai. He also holds post graduate diploma in “Patent Law & Practice” and in “Business Management”; wherein he secured 3rd rank in Mumbai University. He is having about 18 years of industrial experience and worked primarily in area of drug delivery, apart from marketing and business development.
He has about 10 patents, 20 publications and more than 30 presentations at national and international conferences. He is recipient of various awards, prominent being the winner of Elevator’s Pitch Award at Young Entrepreneur Scheme, UK, Leadership Award 2018 – presented by Express Pharma for his contribution to the pharmaceutical industry and Top Pharma Innovation Award at The Pharma Gorilla, 2019.
CEO- QbD International, United Nations Adviser.
CEO- QbD International, United Nations Adviser.
In a career span of 50 years, have rich & varied experience in the Pharma Industry, especially in Quality
Management, R&D, Mfg.-US FDA / EU / WHO etc. compliances.Expert on Quality by Design / Data Integrity / CAPA / Quality Culture & various other CGMP subjects.
Expert Auditor of “Formulations” & “API” facilities / CRO etc.
Worked as Quality Expert with World Bank- Washington USA. Worked with Saudi Arabia FDA for generating the regulations and training SFDA inspectors on behalf of World Bank.
Worked with PFIZER LTD./ Sun Pharma / Lyka Labs, Cancer Research Institute Mumbai. Retired as “Global Quality Head / Vice President” in 2006.
Travelled extensively across the Globe as Chairman & or Speaker at various international conferences. So far 464 presentations given in 70 countries on: “cGMP, QbD, PAT, US FDA / EU Inspections, GCP/GLP, 21 CFR part 11, Technology Transfer, Operational Excellence, ISO, ICH, Risk Management, Regulations, Vendor development /outsourcing etc.” at various International conferences organized by ISPE FDA, Marcus-Evans, IQPC, IPC, CBI (USA), WHO, ISO, UNOPS, Govt. of India, CPHI, FDA of Gujarat, Maharashtra, FDA - AP, FDA - Karnataka etc.
Vice President (Bio Pharma Division), Intas
Vice President (Bio Pharma Division), Intas
Udaykumar is a quality professional with a dynamic career steering organizations through complex Quality & Regulatory challenges, transitions, building an empowered and talented workforce in the cross-cultural environment within highly competitive products and regulatory environment.
He began his career in Quality function as an Executive In-process QA and then moved to different levels and organizations spanning 27 plus years of hands-on and hard-core experience in the pharmaceutical regulatory environment.
He has represented the Organisation as Quality Head and prepared, presented, and attended the regulatory meetings with IAG/ MHRA/ IMB/ USFDA in London and Washington. Has performed 400+ Audits and faced 500+ regulatory audits.
He has gained domain experience in Quality & Operations, specifically focusing and leading the Quality & Regulatory remediation in the last 12 years (2006-2017). He has worked for a decade in Corporate Quality functions, overseeing the Project Management, Toxicological Assessment, Clinical, BA/ BE, API & DF Development & Dossier filing for developed markets and developing economies. Has set up the Global Quality organization for the Manufacturing Site (Multi-product manufacturing), Contract Manufacturing & Testing in regulated and semi-regulated markets.
He founded the consulting firm, PharmaMantra, a Quality Advisory and consulting firm in August 2017. Since then he has performed Training, GAP assessment Audit, Site support during EDQM/ USFDA, Toxicological PDE Certification, and Consulting assignments for Indian and MNC clientele. He has proposed a Corrective Action Plan and worked with senior management to maintain a culture of compliance and trust with regulators. He envisions thorough PharmaMantraTM, he shall be able to provide the Manufacturing and Quality Leaders the desired insights and advice to reach simple sustainable solutions for the seemingly complex situations/ problems/ activities. He has experience which can be shared and adapted for various stages of the Quality System developments and subsequent evolution to demonstrate the desired Culture of Pharmaceutical Quality.
Sr. General Manager and Head- Advanced Biotech Lab (R&D Biosimilar) Ipca Laboratories Ltd.,
Sr. General Manager and Head- Advanced Biotech Lab (R&D Biosimilar) Ipca Laboratories Ltd.,
Sanjeev Gupta has obtained Ph.D. in Molecular Biology/Cell Line Engineering and M.Sc. in Applied Microbiology and Biotechnology. At present working as Sr. General Manager and Head, Advanced Biotech Lab (R&D-Biosimilar), Ipca Laboratories Ltd., Mumbai, India. Sanjeev Gupta has established a new world class state of the art Biotech R&D facility for the development of mAb Biosimilars. He is also actively involved in establishing modern, lean and multiproduct flexible single use Bio-manufacturing facility for Biosimilar development and commercial launch.
He carries around 21 years of industrial experience and has been working since 2000 on the development of “Biosimilars” including monoclonal antibodies. His core expertise lies into Molecular Biology, Cell Line, Upstream process development, Bio-analytical as well as Tech transfer to GMP for clinical and commercial batches.
Till date, he developed and contributed for over twelve recombinant molecules, of which eight Biosimilar products has been already launched in the Indian market and the rest are in the developmental or clinical phase, and are expected to be launched in near future.
During his professional tenure, he worked at various position in reputed Indian biopharmaceuticals industries such as Zydus-Ahmedabad, Wockhardt-Aurangabad, Panacea-New Delhi, Intas-Ahmedabad and at present with Ipca Laboratories, Mumbai.
He delivered talks on Biosimilars in various national and international conferences organized by IBC, Terrapin, BioTrain, IMAPAC, CphI, Biopharma, Informa, Selectbio and UBM.
He has also published several Research articles (12), Book chapters (06), Magazines (06) and Patent (01) in lieu of the Biosimilar development.
SBU Head Sales and Marketing Akumentis Health Care Ltd
Founder & CEO, Artixio
Founder & CEO, Artixio
He is the CEO of Artixio, a data analytics Healthtech startup. In his recent roles, he was the Global Head of Business Development for a Bioinformatics company and prior to that, he led the US Business Development and Alliance Management for a US-based, AI-enabled biotech company.
He is an established leader with proven experience in the global biotech and pharma industry. Over the last two decades, he has worked with biopharma companies on various facets across the business value chain including R&D, Business Development, Finance, Sales & Marketing, Talent Management, Commercial Negotiations, and Corporate Strategy.
He has extensive experience of working in various geographies including the USA, EU, and Asia. He is a 2-times TEDx speaker and a keynote speaker/moderator at various industry forums in India and US.
Tarun is a biotechnologist by training, is an MIT Sloan Fellow 2022, has completed his EPBF from IIM Ahmedabad and has a certification of achievement in Immunology and Genetics from Harvard Medical School. He is also a member of various high IQ societies, including TORR - an international society of people with high IQ of 99.87 percentile and above.
Founder, PharmaMantraTM
Founder, PharmaMantraTM
Udaykumar is a quality professional with a dynamic career steering organizations through complex Quality & Regulatory challenges, transitions, building an empowered and talented workforce in the cross-cultural environment within highly competitive products and regulatory environment.
He began his career in Quality function as an Executive In-process QA and then moved to different levels and organizations spanning 27 plus years of hands-on and hard-core experience in the pharmaceutical regulatory environment.
He has represented the Organisation as Quality Head and prepared, presented, and attended the regulatory meetings with IAG/ MHRA/ IMB/ USFDA in London and Washington. Has performed 400+ Audits and faced 500+ regulatory audits.
He has gained domain experience in Quality & Operations, specifically focusing and leading the Quality & Regulatory remediation in the last 12 years (2006-2017). He has worked for a decade in Corporate Quality functions, overseeing the Project Management, Toxicological Assessment, Clinical, BA/ BE, API & DF Development & Dossier filing for developed markets and developing economies. Has set up the Global Quality organization for the Manufacturing Site (Multi-product manufacturing), Contract Manufacturing & Testing in regulated and semi-regulated markets.
He founded the consulting firm, PharmaMantra, a Quality Advisory and consulting firm in August 2017. Since then he has performed Training, GAP assessment Audit, Site support during EDQM/ USFDA, Toxicological PDE Certification, and Consulting assignments for Indian and MNC clientele. He has proposed a Corrective Action Plan and worked with senior management to maintain a culture of compliance and trust with regulators. He envisions thorough PharmaMantraTM, he shall be able to provide the Manufacturing and Quality Leaders the desired insights and advice to reach simple sustainable solutions for the seemingly complex situations/ problems/ activities. He has experience which can be shared and adapted for various stages of the Quality System developments and subsequent evolution to demonstrate the desired Culture of Pharmaceutical Quality.
General Manager - Cytiva, South Asia
General Manager - Cytiva, South Asia
Starting off as an Application Specialist in Promega, Mr Raghavendra Goud later took up various roles in GE Healthcare Life Sciences spanning over two decades. His vast and rich experience in sales and leadership coupled with his educational stints at IIM Calcutta and ISB Hyderabad mark him as one of the finest and beloved leaders in Cytiva. Apart from donning the hat of General Manager, South Asia at Cytiva, he is also a panel member in BIG BIRAC and on the board of numerous Innovation centres.
Human Resources, HR Head, Dr. Reddy’s
Human Resources, HR Head, Dr. Reddy’s
Kaushik is the Head of Human Resources for the Global R&D and associated business units at Dr Reddy's Laboratories Limited. His current responsibilities include shaping the people agenda for the scientific community in the company in order to create leaders in deep science who can extend the frontiers of knowledge and practice. The Global R&D workforce at Dr. Reddy’s is one of the largest and most respected in the world of generics. Over two decades of post qualification experience in HRM, Kaushik took up positions of increasing responsibility in varied roles. He has undertaken multiple organization-wide transformation initiatives designing & creating enabling-structures and organization-effectiveness processes driving exponential growth. Helping companies pursuing inorganic growth strategies, he has led many M&A due diligences, cross-border acquisitions and culture integration exercises. His previous responsibilities include strategic and operational leadership in manufacturing, sales, services and consulting organizations. He has led workforce development practices across staff categories consisting of workmen, supervisory, managerial, consulting and leadership teams. His experiences span across mega-corporations, mid-sized companies and start-ups. Kaushik has earlier worked with leading companies like Infosys, PriceWaterhouse Coopers, Indian Aluminum and HCL Healthcare. An engineer by initial training, he did his MBA in Human Resources from XLRI, Jamshedpur.
Senior Vice President, Research & Development, ModMabTherapeutics, Inc
Senior Vice President, Research & Development, ModMabTherapeutics, Inc
Jagath Reddy Junutula, PhD Senior Vice President, Research & Development, ModMabTherapeutics, Inc. Jagath Reddy Junutula, PhD joined ModMab in December 2018 as a Senior Vice President, Research & Development. Prior to joining ModMab, Jagath was at Cellerant Therapeutics for five years as a Vice President, Research & Development, and responsible in developing two IND-ready antibody-drug conjugate (ADC) therapeutic programs. Jagath was at Genentech for 13 years focusing on oncology drug discovery and development, including discovery and validation of ADCs; engineering next-generation ADCs; and development of bi-specific T-cell engaging antibodies for various cancers. He developed a novel THIOMAB technology platform to generate site-specific ADCs to improve the therapeutic utility of antibodies. He contributed to the development of approved drugs (Kadcyla, Polivy) and clinical site-specific ADC therapeutic candidates (CD79-ADC, MUC16-ADC and HER2-ADC). He led the teams, which discovered and developed a next generation site-specific T-DM1 ADC project and over 10 other ADC/Bi-specific antibody therapeutic candidates. Jagath was a featured inventor in "Greatest Hits in 20 years of Nature Biotechnology Biomedical Research", Nat. Biotechnol. 2016. Jagath obtained his PhD in 1997 from the Indian Institute of Science, Bangalore, India, and did post-doctoral research at Stanford University. Jagath has authored >60 peer-reviewed publications and inventor on >60 patents and has presented his work at numerous international conferences. He received a “Long-standing Contributions to ADC Therapeutic Field” recognition award at the 2017 World ADC Summit, San Diego, CA. Jagath serves as an editorial board member of leading journals, mAbs & ACS Medicinal Chemistry Letters. He served as a President (2010-2011) and Board Chairman (2013-2014) of EPPIC Global.
HR Leader Asia Pacific at Cytiva
HR Leader Asia Pacific at Cytiva
Benjamin James known as Benji leads HR for Asia Pacific that covers ANZ, ASEAN, India, Japan and Korea with 800+ associates across all functions of Cytiva. In his role as HR Business Partner he is responsible for driving impact around transition, culture, employee experience, leadership development, organization structure and strategy. Benji has totally 17 years of HR experience spanning across IT, Engineering and Healthcare companies. Prior to his current role he was the HR Business Partner for GE Healthcare Commercial & Functions team for India. He has worked as Organization and Talent Development leader for GE India Technology Centre in which he has founded and implemented various contemporary organizational & talent development practices that has helped drive key results for the business. Prior to GE, Benji has worked for Hewlett Packard as the HR Business partner for their application services business wherein he has successfully helped set up 2 offshore development centers in India. He started his career with an Indian IT company named HCL Technologies. Benji has been with Cytiva / GE for 8 years now holding various HR positions across various businesses like Power Conversion, Global Research and GE Healthcare. He has a master’s degree in social work from Loyola College and a bachelor’s degree in English Literature.
Sr Vice President, INTAS Pharmaceuticals Ltd. Plasma Fractionation unit
Sr Vice President, INTAS Pharmaceuticals Ltd. Plasma Fractionation unit
Dr. Suma Ray is the Sr Vice President and Site Head for Plasma Operations at the Plasma Fractionation Centre of Intas Pharmaceuticals, India. She is currently responsible for strategic planning of product development, manufacturing, procurement, training, GMP operations, business expansion and other activities of the organization that lead to achievement of corporate goals. She supervises product development and manufacturing under the Indian Pharmacopoeia and EMEA guidelines. She is also responsible for the overall administration of as well as revenue generation for the Plant. Prior to assuming this responsibility, she has worked at various capacities in global roles in the Purification Technologies Division at Sartorius Stedim Biotech. Earlier to that, Dr. Ray worked for Biocon where she was part of the group responsible for setting up a GLP compliant virus laboratory and conduct Virus Validation studies. She has varied expertise in Plasma derived therapeutics, viral vaccines as well as different recombinant therapeutic antibodies. Dr. Ray holds a PhD degree from ´All India Institute of Medical Sciences`, New Delhi, followed by post doctorate fellowships from `Stanford University School of Medicine´ and ´University of Virginia` and has to her credit several publications in the area of haematology, virology and oncology in peer reviewed journals.
Senior Vice President, Clinical Research Aurobindo Pharma Ltd.
Senior Vice President, Clinical Research Aurobindo Pharma Ltd.
Arani Chatterjee, MBBS, MPhil, PGCPM completed his graduation from CMC, Vellore and post-graduation from NIMHANS, Bangalore. He has a Post Graduate Certificate in Management from IIM, Indore. Before joining Aurobindo Pharma, he was Senior Vice President, Clinical Research at Biological E, Hyderabad for 3 years, Panacea Biotec, New Delhi for 9 years and Princpial Research Physician at Dr. Reddy’s Laboratories (Discovery Research), Hyderabad for 6 years. He has an experience of over 23 years, is a visiting faculty at University of Pune and Institute of Clinical Research, member of Expert Committee for PG Diploma in Clinical Research at IGNOU, Academic Board of Studies, Institute of Clinical Research, Hindustan Institute of Medical Sciences & Research, Sharda University and National Committee on Biotechnology of CII. He has served as a WHO Adviser for the Global Polio Eradication Initiative. He is a member of several Brighton Collaboration groups for vaccine safety. His has participated in WHO SAGE and GVSI meetings, pre-IND meetings with USFDA, scientific advice meetings with BfArM (Germany), ANVISA (Brazil), Medsafe (New Zealand), ALIMS (Serbia), expert group meetings on Indian GCP guidelines and Schedule Y, National Technology Advisory Group on Immunisation, Asia Pacific Dengue Prevention Board Meeting under the Pediatric Dengue Vaccine Initiative of International Vaccine Institute and Pneumococcal Vaccines at UNICEF. He has authored 22 papers in peer-reviewed journals and is a recipient of the 2012 Charles C. Shepard Award from CDC, Atlanta.
Founder & CEO, BIORx Venture Advisors Pvt. Ltd
Founder & CEO, BIORx Venture Advisors Pvt. Ltd
Mr Vishal Gandhi Is The Founder & CEO At BIORx Venture Advisors Pvt. Ltd. He Has An Overall 20 Plus Years Of Strong Experience Of Strategic Advisory Deals In Terms Of Investments, Mergers And Acquisitions, India Entry Strategy And Due Diligence Process Exclusively For Healthcare & Agri Sector. He Is Amongst The Top 20 Dedicated Healthcare Investment Bankers In The Country. Biorx Has Helped 75 Private Companies And 8 Foreign Mnc Into Their India Foray Since Its Inception In 2012 Towards Venture Creation, Scale-up And Investable Business Models Companies Ranging From Pharmaceuticals,Biotechnology, Contract Research, Medical Devices, Digital Healthcare, Hospitals Including Super And Single Speciality. He Has Been Often Quoted In Business Papers For His Views Given His Superior Understanding Of The Healthcare Sector. Prior To Biorx, Vishal Has Held Top And Mid Management Positions In Yes Bank, Ranbaxy Research Laboratories,, Oncquest (Intrapreneur, Started Venture With Dabur Support And Is Now Rs 500 Crores Plus Revenue Venture Catering To Niche Molecular Diagnostics Services For Cancer) And Dabur Research Foundation. Vishal Holds A Management Degree FROM XLRI, JAMSHEDPUR and MASTER DEGREE IN BIOTECHNOLOGY from the UNIVERSITY OF HYDERABAD. Vishal Is A Member Of Various Task Forces Of Industry Chamber FICCI, CII, ASSOCHAM AND PHDCCI Also He Has Been Mentoring Startups at CIIE OF IIM AHEMDABAD AND IIT DELHI For A Decade Now And Now Has Been Actively Associated With Many Life Sciences Focused Incubators And Has A Niche Experience Of Policy Advocacy And Has Had Contributed To First-ever National Biotech Strategy Document Published By DEPARTMENT OF BIOTECHNOLOGY, GOVT OF INDIA Through FICCI In The Year 2005.
Associate Director - Global Drug Development - Novartis
Associate Director - Global Drug Development - Novartis
18 +yearsyearsyears of experienceexperience experience experience in leading leading leadingandand building building digital digital solutions solutions using using new new-age agetechnologiestechnologies technologies technologies technologies .RecognizedRecognized Recognized Recognized for forconsistently consistently consistently consistentlydrivingdriving drivingdriving drivingstrategic strategic strategic initiatives initiatives initiatives and digital digital digitaltransformation transformation transformation transformation transformationtransformation efforts effortsefforts to support support support organizational organizationalorganizational organizational organizational organizational goals .Engaging Engaging Engagingleader leaderleader and innovativeinnovative innovativeinnovativeinnovative innovative change change agent agent withwith withexpertiseexpertiseexpertise expertise expertisein solution solution development,development,development,development, development, development, development,development, partnership partnership partnership partnership management, management, management,management, management, and andincreasing increasing increasing increasingvisibilityvisibility visibilityfor business business businessgrowthgrowth growth .Biotechnologist Biotechnologist Biotechnologist Biotechnologist and Bioinformatician Bioinformatician Bioinformatician Bioinformatician withwith withadeepdeep understanding understanding of life sciences and pharma domain
Co-Founder ReaGene Biosciences
Co-Founder ReaGene Biosciences
Dr. Uday Saxena is currently a Co-Founder of start-up Biotech Company, ReaGene Innovations. He has held Executive and Leadership positions at Parke-Davis in Ann Arbor, AtheroGenics in Atlanta (VP Drug Discovery), Dr. Reddy’s Laboratories (Chief Scientific Officer, US and India) and Kareus Therapeutics (CEO). He has a PhD in Biochemistry from Memorial University and Post-doctoral training at Columbia University. He was associated with the Team at Parke-Davis/Pfizer that discovered Lipitor/atorvastatin, the largest selling (peak sales of $17 billion dollars) drug in pharma business. He lead teams that brought several drug candidates from an idea into the clinic. Dr.Saxena’s current research interests are translational product discovery. His passion is to continue being an entrepreneur having initiated biotech companies in the US and India. He is one of the few executives who combine excellence in science as well as business side of pharma including being part of a start-up which was successfully listed on wall street (NASDAQ). He serves as a review member/Mentor to several DBT panels as well as IKP and CSIR programs. He is a well known speaker in International and National platforms and recipient of academic and Industry honors. He has published more than 60 papers and been granted/filed 28 patents.
Cofounder & Managing Director Premas Biotech
Cofounder & Managing Director Premas Biotech
Prabuddha has studied from IIT-Bombay. His specialization is in protein therapeutics and scale up of biomolecules and biosimilars, and MAbs. He has over 20 years of experience in various companies, and positions, including establishment of production facilities, for therapeutics and biologicals, vaccines and blood derived products. In his most recent role, as an entrepreneur, he has co-founded Premas Biotech 15 years ago, along with the team. At Premas, he has managed mutli-group specialties, including manufacturing, and business development, with a keen understanding of the bio-market in India and USA. Premas has become of the top protein research and manufacturing companies in India and globally. Apart from his other business interests, he is most interested in process efficiency enhancement, and has been very actively involved and implemented "Lean Management" at Premas Biotech, or the "Toyota production Process" one of the first company in India for the biology sector, along with electronic information acquisition and documentation. This provides entire bandwidth of traceability, information management and process deliveries. He has over 22 publications in international journals, 8 US patents pending, and 4 patent applications.
EXECUTIVE PRESIDENT - FABA Senior Professor (Retd.), School of Life Sciences, University of Hyderabad
EXECUTIVE PRESIDENT - FABA Senior Professor (Retd.), School of Life Sciences, University of Hyderabad
Works at School of Life Sciences, University of Hyderabad. Works in the area of inflammation biology, specifically on cyclooxygenase and lipoxygenase pathways. Involved in setting up of TBI and BioNEST incubation centers and in promoting innovation and entrepreneurship activities in the campus. Founder member of the Federation of Asian Biotech Associations (FABA), where he currently serves as the Executive President. Recently launched FABA Academy to help students in their career development. Served as the founder director of National Institute of Animal Biotechnology, autonomous institute of the Department of biotechnology, Government of India. Google Scholar Citations at: https://scholar.google.com/citations?user=xCp2iFoAAAAJ
Managing Consultant, TÜV SÜD Digital Service Singapore
Managing Consultant, TÜV SÜD Digital Service Singapore
Antonio is Managing Consultant for Industry 4.0. He is responsible for supporting the process manufacturing sector, in adopting I4.0 technologies to enable end to end integration, to improve HSE and optimizing efficiency. With a PhD in Artificial Intelligence, a background in Industrial Engineering, Antonio ran successful projects in Oil and Gas, Mining and Pharma, and has been part of several international initiatives in EU and ASEAN, as a Digitization and Industry 4.0 expert. He worked as R&D manager , strategy and management consultant and technology advisor before and developed a comprehensive experience in AR, VR, AI, business process optimisation, project management in several sectors such as energy efficiency and robotics. Antonio is also Professor and Chair of Corporate Governance at the University of Vitez and trainer at the National University of Singapore. He delivers for industry and academia in both technical topics as Predictive Maintenance, and non-technical ones like Management of Innovation Processes and Technology Transfer Strategies.
Pharma 4.0 consulting lead at TÜV SÜD Digital Service Singapore
Pharma 4.0 consulting lead at TÜV SÜD Digital Service Singapore
As the Pharma 4.0 consulting lead at TÜV SÜD Digital Service Singapore, Pushkar helps life sciences companies initiate, scale and sustain their digital transformation journeys. A chemical engineer by training, he holds a PhD in modelling of complex biological systems from the University of Maryland, College Park. He has over eight years of diverse experience in life sciences, from small molecule drugs, biosimilars to novel biologics. He specialises in advanced analytics and has led multiple digital innovation projects such as digital twins, virtual sensors and predictive maintenance across the biopharma value chain, from R&D to manufacturing operations. Pushkar is a member of the global Pharma 4.0 working group at the International Society for Pharmaceutical Engineering (ISPE) and sits on the executive council of ISPE’s Singapore chapter.
Senior Director – Life Sciences Solutions, South Asia Thermo Fisher Scientific
Senior Director – Life Sciences Solutions, South Asia Thermo Fisher Scientific
Kapil has three decades of leadership experience. He first built his career in the technology industry and was leading Sun Microsystems and then Tektronix in India. Inspired by the Thermo Fisher mission of enabling our customers to make the world healthier, cleaner, and safer and the opportunities this presents for impacting the lives of people in a true sense, he became part of Thermo Fisher Scientific. He now manages the business of Life Sciences Solutions Group for South Asia and also leads all the global teams based out of Bangalore. Kapil has a bachelor’s degree in engineering. He is also a Fulbright Fellow and completed ‘Leadership in Management’ program from Carnegie Mellon University.
Product Manager, Premas Life sciences Pvt Ltd
Product Manager, Premas Life sciences Pvt Ltd
Dr. Tani Agarwal has graduated from Delhi university studying Zoology and mastered in Biomedical research. She received the CSIR Catch Them Young Fellowship as well as CSIR-JRF during her PhD. She holds a PhD from CSIR-IGIB where she learned a thing or two about biophysical characterization of DNA structure. She has furthered her research experience with post-doctoral research on protein biochemistry of Eukaryotic Replisomes from Rockefeller University, USA. After her stint at academic teaching for a while, she took to pursue further postdoctoral research work at Nanyang Technological University, Singapore. She has varied experience across biophysical and biochemical characterization of biomolecules and has authored seven peer reviewed articles. Currently, her interest is in helping industry researchers connect with the best global technology solutions for modernizing life science research. Apart from research, she is a full-time mother and a passionate public speaker. She often imparts popular science talks and mentors' young researchers in their scientific endeavors.
Ph.D. (Delhi), D.Phil. (Oxford), FNA, FNASc Arturo Falaschi Emeritus Scientist, ICGEB EC Chairman, National Assessment & Accreditation Council NAAC, Govt. of India
Ph.D. (Delhi), D.Phil. (Oxford), FNA, FNASc Arturo Falaschi Emeritus Scientist, ICGEB EC Chairman, National Assessment & Accreditation Council NAAC, Govt. of India
Prof. Chauhan obtained his Bachelors, Masters and Doctorate degree in Chemistry from Delhi University. He won the highly prestigious Rhodes scholarship in 1974 to study at Oxford University where he obtain his DPhil Degree in 1977. Upon his return to India in 1979, he taught at St. Stephen’s College, IIT - Kanpur, and Delhi University. In addition to a brilliant academic record, he has also been an outstanding sportsman and represented Delhi University, Delhi State and Oxford University in athletics and cross country running. In 1988, he joined the International Centre for Genetic Engineering and Biotechnology (ICGEB) and became its Director in 1998, a position he held until 2014. Dr. Chauhan is a distinguished, internationally recognized scientist of India, his research interests are in the fields of infectious diseases particularly in malaria vaccine and drug development and in study of peptides of biological importance. His scientific interests also include advocacy in infectious diseases particularly TB and Malaria in India. He has published more than 270 research papers and guided more than 55 research students. Dr. Chauhan is an elected fellow of all the three major National Science Academies as well as a fellow of the Third World Academy of Sciences. Dr. Chauhan has been deeply involved in human resource development through major involvement in selection process of highly prestigious scholarships including the Rhodes Scholarships, the Inlaks and Felix Scholarships for Indian students to study abroad. Prof. Chauhan has received many prestigious national and international awards including civil honour Padma Shri in 2012. Dr. Chauhan is a member of the core committee of National Institutional Ranking Framework (NIRF). He is also Chairman of the National Assessment and Accreditation Council (NAAC). He was Chairman of University Grants Commission (UGC) in 2017. Dr. Chauhan was also Chairman of the Pay Review Committee for the 7th Pay Commission for all government funded institutions of Higher Education. Dr. Chauhan continuous his research as a Visiting Scientist at ICGEB as a J. C. Bose Fellow & Distinguished Biotechnology Research Professor (Department of Biotechnology).
Global Practice Head Life Sciences
Global Practice Head Life Sciences
A seasoned professional with over two decades of experience in strategic leadership in life sciences. Recognized as an industry expert and trusted advisor to the business partners and customers. Patents: 2 Patents filed on the application of digital technologies in fostering Drug Discovery. Research Grant: Co-Project Investigator in a project granted by Dept of Biotechnology-BIRAC (Govt of India)
Co-Founder & COO At Biorx Strategic Leadership Alliance
Co-Founder & COO At Biorx Strategic Leadership Alliance
Ms Pritika Kalra Is the Co-Founder & COO At Biorx Strategic Leadership Alliance [BSLA]. She Has An Over 10 Plus Years Of Strong Experience Operations, Events, Communications and overall management at BIORx. Pritika holds A Master's Degree is Political Science from the University of Delhi as well as post graduate diploma in Journalism from Bharatiya Vidya Bhawan. She brings a wealth of experience to her current portfolio as she has worked as an editor, feature writer and a communications specialist in various power and energy related magazines like the Power Line. She has also worked at The Energy Resources Institute and at the WInrock International India in the past.
Vice-President, Eight Roads Ventures
Founding Partner at Bharat Innovation Fund
MD & CEO at Stempeutics Research Pvt. Ltd.
Associate Vice President and Head of Bioprocess Group at Biotech & Genomics division, Wockhardt Research Center, Aurangabad
Associate Vice President and Head of Bioprocess Group at Biotech & Genomics division, Wockhardt Research Center, Aurangabad
Dr. Dakshesh Mehta is currently the Associate Vice President and Head of Bioprocess Group at Biotech & Genomics division, Wockhardt Research Center, Aurangabad. At Wockhardt, he leads group of process development scientists for development of biosimilar recombinant therapeutic proteins (Insulins, MAbs, Hormones). His responsibilities includes, DNA construct design for expression, selection of higher producer clones, generation and characterization of cell banks, process development (fermentation and purification) to obtained recombinant proteins with desired quality, technology transfer and scale up to pilot and manufacturing plant, Support to analytical development, manufacturing, Quality and regulatory team. Before joining Wockhardt, Dr. Mehta was working at Aurigene Discovery Technologies, Dr. Reddy's subsidiary, Bangalore as a Protein Scientist, where he was involved in expression and purification of drug target proteins for structural and functional studies. Dr. Mehta holds a M.Sc. and Ph.D. degree in Biotechnology from IIT, Mumbai with specialization in molecular biology and yeast genetics. He was a post-doctoral fellow at M.D. Anderson Center, Houston, Texas USA and was also a visiting scientist at National Institute of Environmental Health Science, NIH, Research Triangle Park, USA. He has several publications to his credit. Dr. Mehta has been invited as speaker at various national and international forums.
Co-Founder & Director at Reagene Innovations Pvt Ltd
Chief Operating Officer at Syngene International Limited
Program Manager National Biopharma Mission DBT BIRAC
Co-founder and CEO at Ahammune Biosciences Private Limited
Managing Director at KOOL - EX COLD CHAIN LIMITED
Country Head, JSS Medical Research India Pvt Ltd
Country Head, JSS Medical Research India Pvt Ltd
Dr. Ajoy Kumar is now the Country Head of JSS Medical Research India Pvt Ltd. which is a Drug Discovery KPO. He has been with JSS/Max Neeman since 2005.Prior to all he was President, Apollo Hospitals. He was the Chief Executive Officer of the Max Neeman International, a tributary of the Max India Group. He has served as the CEO of the company since May, 2005. Under the leadership of Dr. Ajoy Kumar Max Neeman International’s identity has undergone a huge transformation which has made India’s leading Contract Research Organization. In his current role as CEO of Max Neeman International he is responsible for overseeing the global business operations of the Company and is focused on stable growth, client satisfaction and long-term relationships. Dr. Kumar has a meritorious track record, and the experience of managing large business operations like Apollo Hospitals, Cumin Diesel and Tata sons. At Apollo Hospitals, Dr Kumar was responsible for overseeing operations of the group hospitals, and other businesses of Apollo. He initiated Apollo Clinical Excellence Model, Emergency Network, and development of common corporate database. And also conceptualized and implemented the disease management program for the Apollo Group, and was leader of the nationwide Apollo Heart Plan. Dr Ajoy Kumar is a MBBS holder from Jawaharlal Nehru Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry with post-graduate diplomas in business administration, hospital administration and preventive and promotional healthcare. He is also a Certified Black belt in Six Sigma. After graduating in medicine from JIPMER, Pondicherry he joined the Indian Police Service (IPS) as a Superintendent of Police, Patna. He also administered East Singhbhum including the city of Jamshedpur as Superintendent of Police. Dr. Ajoy Kumar is the recipient of Police Gallantry Medal in 1988, the youngest IPS Officer to get President’s Police Medal for Gallantry.
Executive Director at Serum Institute of India Limited
Advocate & Patent Attorney, SKS Law Associates
VP, Endiya Partners
VP, Endiya Partners
Nita Sachan works at Endiya partners as VP for their healthcare investments. Endiya partners is an early-stage venture capital investment firm. Nita Sachan comes with rich healthcare experiences across industry and academia. She has over 20+ years of experience working at the interface of business solutions, innovation and technology. Her expertise lies in the areas of Medical Devices, Genomics, Biotech and Pharmaceuticals. She has worked across organizations such as Cyient, Medtronic, Mapmygenome, Indian School of Business (ISB) and University of Southwestern (UTSW) medical center at Dallas. She is a strategist with insights on product development and business model innovation. She received her PhD from University of Kentucky, MBA from Indian School of Business (ISB) and MS from IIT Roorkee.
Vice President- Business Development, Pluss Advanced Technologies
Vice President- Business Development, Pluss Advanced Technologies
Udit is a management post-graduate specializing in Marketing & Finance from Management Development Institute (MDI) Gurgaon and has a Bachelors in Technology in Biotechnology from Amity University, Noida, India. Udit has over 11 years of experience in the area of life sciences and healthcare. Before joining at Pluss, he has held different roles ranging from product management to business management in several companies in the life science industry including in Bio-Rad Laboratories and Thermo Fisher Scientific. Udit now leads healthcare and agriculture business verticals at Pluss - from strategizing the new product development to identifying business growth opportunities. He has won several awards in business management and product development and has been a speaker at several public and private conferences. One of the latest innovations he is working on is an affordable, electricity free infant warmer for low birth weight new born babies supported by BIRAC and CMC Vellore.
Former Sr.Vice President & Chair, R&D, Cadilla Pharmaceuticals
COO & Director - Chiro Behring Vaccines (A Group Company Bharat Biotech International Limited
Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. Our customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Our job is to supply the tools and services they need to work better, faster and safer, leading to better patient outcomes. Cytiva is a global life sciences leader with over 7000 associates across 40 sites who are dedicated to our vision to improve access to life-changing therapies that transform human health. As a trusted partner to customers that range in scale and scope, Cytiva brings efficiencies to research and manufacturing workflows, ensuring the development, manufacture and delivery of transformative medicines to patients.
Company Profile : JNC CORPORATION / MR SANGHAVI & CO. We are in the business of providing Biotech, Bio-Pharma, Fine Chemicals & Academia solutions. With state-of-the-art chromatography bulk media, resins, gels & equipment from the world’s best companies, we strive to always offer excellent technical solutions & support. The Cellufine™ product line offers a broad range of chromatography resins for the purification of proteins, enzymes, and biomolecules. The media is based on spherical cellulose beads, and exhibits high chemical stability, mechanical strength, higher flux and is inherently bio-compatible. Applications include protein or polysaccharide purification, endotoxin removal, and is used worldwide for purifying vaccines, therapeutic enzymes, and virus concentration or purification. Cellulose media have significantly lower Leachables than comparable polymeric beads. Gel Filtration, IEX, Affinity, and HIC media available for broad range of biomolecules and applications. Cellufine customizes media, ligands or bead sizes for challenging purification process. Besides growing and consolidating the international marketing business of industrial products and chemical specialties, we undertake forward and backword integration activity to produce tailor-made value-added specialty products. “Our mission is to become a benchmark organization in this line of business by striving consistently to develop our organization, infrastructure & professional skills to be highly effective in this competitive environment.”
“Pfanstiehl is the market leader of high purity / low endotoxin-low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all of the leading global biopharmaceutical companies. Pfanstiehl was founded in 1919 and currently celebrating its 102nd anniversary year in 2021. Pfanstiehl is headquartered at Waukegan, IL, USA and has global presence with sales offices in Switzerland for EMEA & in Singapore for APAC. Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s excipients are critical components in the majority of the top ten global blockbuster biopharmaceutical drugs which have been administered to thousands of patients around the world. Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high purity, performance, consistency and quality attributes. For more information about Pfanstiehl and our products and solutions, please contact our business development representative for India; Mr. Aniket Chaudhari at aniket.chaudhari@pfanstiehl.com or Mr. Hemasunder Reddy, Director – APAC at hemasunder.reddy@pfanstiehl.com or visit www.Pfanstiehl.com”
TÜV SÜD is a trusted partner of choice for safety, security and sustainability solutions. We specialise in testing, certification, auditing and advisory services. Since 1866, we have remained committed to our purpose of enabling progress by protecting people, the environment and assets from technology related risks. Through more than 25,000 employees across over 1,000 locations, we add value to customers and partners by enabling market access and managing risks. By anticipating technological developments and facilitating change, TÜV SÜD inspires trust in a physical and digital world to create a safer and more sustainable future.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.
Premas Life Sciences- Introducing cutting-edge technologies for the advancement of Biopharma/Pharma, Research and Clinical Diagnostics in India. Incepted in 2011 by a team of highly experienced and proficient professionals, Premas Life Sciences Private Limited (PLS) is engaged in technology and knowledge distribution of proteomics, molecular biology, genetics, genomics and synthetic biology state-of-the-art niche solutions for the Indian Research and applied markets. With the advent of the era of genomics & proteomics, leveraging the latest technology to gain an edge in mining and interpreting information has become imperative. With our ensemble range of products, we aim to provide innovative solutions to meet the ever-growing demand and over-coming the challenges of Biopharma/Pharma Industries from Drug discovery & development to QC. Our dynamic portfolio of leading global technologies boasts some of the most exciting protein sciences, synthetic biology and cell biology applications, manufactured by global giants like Codex DNA, Unchained Labs, Illumina, Fluidigm, 10X genomics, Acea Biosciences etc. which has tremendously boosted the popularity of the company. The organization has been recognized as India’s greatest brands in the Lifescience category by Asia One. The firm can rightly boast of rare and exclusive contribution to the country’s research mechanism by providing some of the most creative and time-tested tools. Over the years, PLS’s dedicated and persistent client-centric approach has transformed this enterprise from a young start-up to an established leader with a CAGR of 60% in a very short span of time. In the quest to boost research & industrial outcomes, PLS looks forward to keep unveiling exciting technologies and develop newer markets in the Lifesciences domain.
Vision Our Vision Is To Enable Sustained Long Growth By Enhancing Shareholder Value By Devising Comprehensive Customized Solutions To Financial And Business Development Issues Of Our Clients.
Mission Our Mission Is To Become The Most Preferred Financial And Strategic Partner For The Life-sciences Industry Of India.
Express Pharma, today India’s leading business fortnightly for the pharmaceutical industry
Pharma Utility, a magazine dedicated to news and services in the Indian pharmaceutical industry.
India's most comprehensive online pharma news service. It provides updates on Indian pharma industry
IJDRA is Quarterly Open-access and peer-reviewed Journal circulated electronically and Print since 2013 .
Copyright @ 2020 bluetech-media.com, All Rights Reserved,
Design & Develope by webtech.ooo